secwatch.observer — SEC 8-K summary
======================================

Issuer:     Phio Pharmaceuticals Corp. (PHIO)
CIK:        0001533040
Form:       8-K
Filed at:   2025-01-17T23:59:59+00:00
Accession:  0001683168-25-000426
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Phio raises $1.83M via registered direct offering and warrant private placement
-------------------------------------------------------------------------------

- Sold 610,000 shares at $3.00 each; issued warrants for 1,220,000 shares at $3.00 exercisable for 24 months.
- Gross proceeds $1.83M; net ~$1.6M after fees; proceeds to be used for working capital and general corporate purposes.
- H.C. Wainwright acted as placement agent; offering closed January 17, 2025.
- Unregistered warrants issued under Section 4(a)(2); Company must register underlying shares within 30 days.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1533040/000168316825000426/0001683168-25-000426-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1533040/000168316825000426/phio_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-25-000426

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer